Larimer County, Colo., funds by Health and Human Services, Department of
Listing $22,302,531.23 in stimulus funds from Health and Human Services, Department of for Larimer
Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.
Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.
| Recipient | Amount | Description | Federal Dept./Agency | Date |
|---|---|---|---|---|
| COLORADO STATE UNIVERSITY | $6,063,912 | National Center for Research Resources, Recovery Act Construction Support This proposal requests funds to complete construction of an Imaging Facility devoted to work with BSL- 3 pathogens and Select Agents and to provide an underground electrical feed to the Imaging Facility and the rest of the Infefectious Disease Research Cent... Show more | National Institutes of Health | 3/25/2010 |
| COLORADO STATE UNIVERSITY | $1,998,452 | Trans-NIH Recovery Act Research Support The global epidemic of tuberculosis continues unabated. A particularly dangerous family of clinical strains is the 'W-Beijing' family, many of which are highly drug resistant [MDR]. The substantial and relatively rapid transmission of these strains across | National Institutes of Health | 9/30/2009 |
| COLORADO STATE UNIVERSITY | $1,710,939 | Trans-NIH Recovery Act Research Support This application proposes to continue the Rocky Mountain Regional Center of Excellence (RMRCE) for Biodefense and Emerging Infectious Diseases Research located in Region VIII. The RMRCE consists of a highly integrated consortium of universities and federa | National Institutes of Health | 9/17/2009 |
| COLORADO STATE UNIVERSITY | $1,286,313 |
Trans-NIH Recovery Act Research Support The long term goal of our program is to develop novel broad spectrum chemotherapeutics that can be used for Phase 1 clinical trials for treating the diseases caused by priority pathogens such as Francisella tularensis, Burkholderia pseudomallei and Yersin
This spending item is part of a $1,958,105 allocation.
See details
|
National Institutes of Health | 8/30/2010 |
| HUMAN SERVICES, COLORADO DEPARTMENT OF | $1,265,067 |
ARRA Child Care and Development Block Grant The CCDF ARRA funds will be used to provide child care financial assistance to low-income working families and fund activities to improve the quality of child care.
This spending item is part of a $24,312,305 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| COLORADO STATE UNIVERSITY | $692,382 |
Trans-NIH Recovery Act Research Support This is a research project to develop a new 'smart sampler' to provide cost-effective, time-resolved monitoring of chemical constituents of ambient particles, with application to characterization for environmental health studies. The project uses scientis
This spending item is part of a $2,691,763 allocation.
See details
|
National Institutes of Health | 6/05/2010 |
| COLORADO STATE UNIVERSITY | $674,966 | Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (06) Enabling Technologies, and specific Challenge Topic 06-CA-102: Transient Molecular Complexes in Cancer. Virtually all cellular processes, including those involved in cell growth, differentiation, and ap | National Institutes of Health | 9/28/2009 |
| COLORADO STATE UNIVERSITY | $614,521 |
Trans-NIH Recovery Act Research Support The long term goal of our program is to develop novel broad spectrum chemotherapeutics that can be used for Phase 1 clinical trials for treating the diseases caused by priority pathogens such as Francisella tularensis, Burkholderia pseudomallei and Yersin
This spending item is part of a $1,958,105 allocation.
See details
|
National Institutes of Health | 9/17/2009 |
| COLORADO STATE UNIVERSITY | $582,716 | Trans-NIH Recovery Act Research Support Mosquito-borne viral diseases remain significant causes of morbidity and mortality throughout much of the world and impose tremendous burdens on human and animal care infrastructures. It is critical that we have a better understanding of the molecular bas | National Institutes of Health | 8/11/2009 |
| COLORADO STATE UNIVERSITY | $577,038 | Trans-NIH Recovery Act Research Support The pituitary transcription factor, Pit-1, is responsible for both normal development of the anterior pituitary gland and cell specific expression of three of the pituitary peptide hormones. A clear understanding of the regulation of transcription and cel | National Institutes of Health | 8/10/2009 |
| COLORADO STATE UNIVERSITY | $576,410 |
Trans-NIH Recovery Act Research Support Prion diseases are infectious, conformational neurodegenerative disorders characterized by the structural modicfication of the prion protein, PrPC, into a pathological conformer, PrPSc. Currently there is no effective therapy for this group of diseases.
This spending item is part of a $1,242,287 allocation.
See details
|
National Institutes of Health | 9/15/2009 |
| LARIMER, COUNTY OF | $499,574 |
ARRA - Community Services Block Grant The purpose of the CSBG program is to provide a range of services and activities having a measurable impact on causes of poverty in local communities. CSBG Recovery Act funds shall be distributed as pass-through grants to eligible entities serving all 64
This spending item is part of a $8,684,648 allocation.
See details
|
Administration for Children and Families | 4/10/2009 |
| COLORADO STATE UNIVERSITY | $478,393 | Trans-NIH Recovery Act Research Support This proposal outlines a plan for capacity building at the Rocky Mountain Regional Biocontainment Laboratory (RMRBL) at Colorado State University. The RMRBL is one component of the CSU Foothills Campus Infectious Disease Research Center (IDRC). By 2010, t | National Institutes of Health | 7/16/2009 |
| INVIRAGEN, INC. | $426,709 |
Trans-NIH Recovery Act Research Support Chikungunya virus (CHIKV) is an emerging, mosquito-borne alphavirus and potential biological weapon that has caused debilitating, chronic arthralgia in at least 2 million persons in Asia and Africa since 2005. CHIKV was recently placed on the National In
This spending item is part of a $1,933,570 allocation.
See details
|
National Institutes of Health | 7/30/2009 |
| COLORADO STATE UNIVERSITY | $423,151 | Trans-NIH Recovery Act Research Support Tremendous advances in ion channel research have been made with respect to channel structure and function. However, there is a lack of information regarding how living cells process ion channel proteins in real time. Such information is important since ra | National Institutes of Health | 9/16/2009 |
| COLORADO STATE UNIVERSITY | $400,008 | Trans-NIH Recovery Act Research Support HIV protease is a well established target for the inhibition of viral replication and there are a handful of FDA- approved drugs that are being used to weigh down HIV protease activity. However, these drugs are exclusively targeted to the catalytic site o | National Institutes of Health | 6/04/2009 |
| COLORADO STATE UNIVERSITY | $398,863 | Trans-NIH Recovery Act Research Support In the early stages of Mycobacterium tuberculosis (Mtb) infection, irreversible tissue necrosis occurs as the result of localized lung inflammation. The bactericidal mechanism of macrophages and neutrophils, that are supposed to control the infection, in | National Institutes of Health | 7/22/2009 |
| COLORADO STATE UNIVERSITY | $324,264 | Trans-NIH Recovery Act Research Support Poliovirus is the best-known member of a large family of viruses that have genomes made of RNA. These viruses carry a gene for a very specific RNA dependent RNA polymerase protein that is responsible for replicating the virus genome. The focus of this res | National Institutes of Health | 7/22/2009 |
| COLORADO STATE UNIVERSITY | $304,822 |
Trans-NIH Recovery Act Research Support The goal of this proposal is to perform the integrated multi-disciplinary large animal studies needed to advance clinical treatment and assessment of articular cartilage injury and degeneration in the United States. Microfracture, a simple and minimally i
This spending item is part of a $1,730,845 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| COLORADO STATE UNIVERSITY | $249,406 | Trans-NIH Recovery Act Research Support Fatty liver disease is poorly understood and the factors that promote liver damage in this disease have not been identified. This application investigates the hypothesis that the amount of saturated fatty acids delivered to or stored within the liver cont | National Institutes of Health | 7/30/2010 |
| POUDRE SCHOOL DISTRICT | $211,373 | ARRA - Head Start The Poudre School District Early Childhood Program was awarded for both COLA and Quality Improvements Grant for Head Start and Early Head Start. PSD has identified the ARRA COLA to assist in providing salary increases to all staff. The PSD Human Resources | Administration for Children and Families | 6/30/2009 |
| COLORADO STATE UNIVERSITY | $189,659 |
Trans-NIH Recovery Act Research Support The goal of this proposal is to perform the integrated multi-disciplinary large animal studies needed to advance clinical treatment and assessment of articular cartilage injury and degeneration in the United States. Microfracture, a simple and minimally i
This spending item is part of a $1,730,845 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| COLORADO STATE UNIVERSITY | $152,830 | Trans-NIH Recovery Act Research Support The luminal diameter of muscular arteries and arterioles of the microcirculation is the principal site of control of vascular resistance. These small blood vessels are significant regulators of blood pressure and local blood flow distribution, and impaire | National Institutes of Health | 7/16/2009 |
| COLORADO STATE UNIVERSITY | $150,000 | Trans-NIH Recovery Act Research Support Public Health Relevance: Tuberculosis is one of the most important diseases in the world. As recently emphasized by an NIAID document, virtually nothing is known about the host response to, and basic biology of, the rapidly spreading epidemic of MDR stra | National Institutes of Health | 9/11/2009 |
| COLORADO STATE UNIVERSITY | $147,000 | Trans-NIH Recovery Act Research Support The emergence of multi-drug resistant (MDR) strains of Mycobacterium tuberculosis has led to a critical need for new therapeutic agents against tuberculosis. M. tuberculosis is endowed with a diverse range of glycosylphosphatidylinositides such as phospha | National Institutes of Health | 5/07/2009 |
| COLORADO STATE UNIVERSITY | $147,000 | Trans-NIH Recovery Act Research Support We will develop controlled vocabularies (sets of standardized and defined terms) and ontologies (sets of standardized and defined controlled vocabulary terms and their inter-relationships) for vector surveillance and vector management. Use of these contro | National Institutes of Health | 6/04/2009 |
| EARLY CHILDHOOD COUNCIL OF LARIMER C | $136,109 |
ARRA Child Care and Development Block Grant The CCDF ARRA funds will be used to provide child care financial assistance to low-income working families and fund activities to improve the quality of child care.
This spending item is part of a $24,312,305 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| COLORADO STATE UNIVERSITY | $135,474 |
Trans-NIH Recovery Act Research Support This request for supplementary funds for R01-GM-077231 is to fund a collaboration between the lab of Professor Kathleen Hall at Washington University School of Medicine, St Louis, MO (parent grant) and that of Associate Professor Alan Van Orden at Colorad
This spending item is part of a $308,959 allocation.
See details
|
National Institutes of Health | 9/18/2009 |
| COLORADO STATE UNIVERSITY | $132,013 |
Trans-NIH Recovery Act Research Support This application addresses the broad Challenge Area (08), Genomics, and the specific Challenge Topic (08-ES-106), The role of environmental exposure in copy number variation (CNV). CNV events are deletions or duplications that are too small to be recogniz
This spending item is part of a $993,020 allocation.
See details
|
National Institutes of Health | 9/26/2009 |
| COLORADO STATE UNIVERSITY | $127,981 | Trans-NIH Recovery Act Research Support Metnase is a human protein with a SET (lysine methylase) domain and a Mariner transposase (nuclease) domain. Metnase is implicated in several aspects of DNA dynamics. Metnase promotes integration of DNA in a sequence-independent manner, but it is not know | National Institutes of Health | 1/15/2010 |
| COLORADO STATE UNIVERSITY | $110,979 | Trans-NIH Recovery Act Research Support Program ENERGY`s long-term goal is to reduce the rate of obesity & type 2 diabetes (T2D) in elementary school students by teaching & reinforcing healthy behavior choices. Obesity & T2D are epidemics among our children and effective, feasible, sustainable, | National Institutes of Health | 9/17/2009 |
| COLORADO STATE UNIVERSITY | $110,250 | Trans-NIH Recovery Act Research Support Our overall goal is to elucidate the pathways and mechanisms involved in regulated mRNA stability and post-transcriptional control in general. These processes play a very important role in controlling gene expression related to cell growth and differentia | National Institutes of Health | 7/17/2009 |
| COLORADO STATE UNIVERSITY | $108,000 | Trans-NIH Recovery Act Research Support proposal is presented for the formal training of a veterinary surgeon in the molecular and genetic aspects of cartilage repair. The candidate is board certified with the American College of Veterinary Medicine, and possesses a Master of Science in Pharmac | National Institutes of Health | 9/18/2009 |
| COLORADO STATE UNIVERSITY | $99,900 | Trans-NIH Recovery Act Research Support Chromosomal aberrations figure prominently as the underlying cause of many untoward biological effects caused by exposure to ionizing radiation (IR). These include acute effects responsible for cell and organism death, as well as delayed effects, principa | National Institutes of Health | 9/21/2009 |
| COLORADO STATE UNIVERSITY | $99,600 | Trans-NIH Recovery Act Research Support The primary goal of the original and newly proposed studies is to identify possible therapeutic targets for the prevention and treatment of obesity and/or anorexia. This proposal for an administrative supplement will expedite and expand upon the parent pr | National Institutes of Health | 12/18/2009 |
| COLORADO STATE UNIVERSITY | $98,621 |
Trans-NIH Recovery Act Research Support Tuberculosis is a leading AIDS-associated, opportunistic infection and globally it has been estimated that twenty percent of AIDS patients die from tuberculosis. In this study we propose to explore and develop a novel class of nitroaromatic anti-tuberculo
This spending item is part of a $880,429 allocation.
See details
|
National Institutes of Health | 6/18/2010 |
| COLORADO STATE UNIVERSITY | $73,500 | Trans-NIH Recovery Act Research Support This present project proposes a quantitative examination of the factors that impact program completion among a population of students in the first campus drug court program in the U.S. called Back on TRAC (BOT). The BOT program addresses a growing need to | National Institutes of Health | 7/16/2009 |
| THOMPSON SCHOOL DISTRICT R2J | $69,514 | ARRA - Head Start ARRA Cost of Living Adjustment (COLA), and Quality Improvement Funding consistent with the provisions of Section 640(a)(5) of the Head Start Act: COLA/QI Increases to Salary and Benefits and Quality Improvement supported training costs and related supplie | Administration for Children and Families | 6/30/2009 |
| PLASMA CONTROLS, LLC | $67,997 |
Trans-NIH Recovery Act Research Support Plasma Controls is investigating plasma-based ion implantation & deposition (PBII&D) as a method to deposit biomedical coatings on titanium-based materials commonly used in dental implant devices. The goal of the project is to deposit a high quality coati
This spending item is part of a $99,996 allocation.
See details
|
National Institutes of Health | 8/11/2009 |
| COLORADO STATE UNIVERSITY | $58,800 |
Trans-NIH Recovery Act Research Support potent inhibition of HIV-1 infection in cultured cells. We will extend our analyses of these constructs to primary CD34+ cells and T-lymphocytes as part of specific aim 1. In aim 2 further analyses of the functional role of HIV-1 RNA trafficking through t
This spending item is part of a $187,587 allocation.
See details
|
National Institutes of Health | 8/23/2010 |
| LARIMER, COUNTY OF | $55,581 |
ARRA - Immunization Colorado Immunization Program (CIP) ARRA funds are being used to purchase vaccine and support Vaccination projects that will result in increased coverage to all Colorado citizens for vaccine preventable diseases. These funds enable the CIP to distribute 2
This spending item is part of a $1,686,998 allocation.
See details
|
Centers for Disease Control and Prevention | 9/24/2009 |
| LARIMER, COUNTY OF | $46,270 |
ARRA - Immunization Funding will be used to develop the capacity for billing health insurance plans for services provided to health plan members by state and local health department clinics.
This spending item is part of a $490,402 allocation.
See details
|
Centers for Disease Control and Prevention | 9/16/2009 |
| County of Larimer | $42,686 |
Aging Congregate Nutrition Services for States Congregate Meals - ARRA this is for the Elderly population 60 years and over including the at-risk population. These meals are provided at a congregate nutrition site throughout the State of Colorado.
This spending item is part of a $847,851 allocation.
See details
|
Administration on Aging | 3/17/2009 |
| COLORADO STATE UNIVERSITY | $34,274 | Trans-NIH Recovery Act Research Support Chronic intoxication with manganese (Mn) is the cause of a degenerative movement disorder, termed manganism, with clinical features that resemble Parkinson`s disease. Recent findings suggest that injury to this region of the brain involves perturbation of | National Institutes of Health | 7/11/2009 |
| ADVANCED MICROLABS, LLC | $32,240 | Trans-NIH Recovery Act Research Support This grant provided research experience for a total of four people to work as interns in health-related scientific research. | National Institutes of Health | 5/29/2009 |
| COLORADO STATE UNIVERSITY | $31,999 |
Trans-NIH Recovery Act Research Support Plasma Controls is investigating plasma-based ion implantation & deposition (PBII&D) as a method to deposit biomedical coatings on titanium-based materials commonly used in dental implant devices. The goal of the project is to deposit a high quality coati
This spending item is part of a $99,996 allocation.
See details
|
National Institutes of Health | 8/11/2009 |
| COLORADO STATE UNIVERSITY | $30,639 | Trans-NIH Recovery Act Research Support 670,000 new cases of leprosy were detected during the year 2002. What are the factors that contributed to this high incidence even though effective multidrug therapy implemented by the World Health Organization has been used to treat leprosy patients over | National Institutes of Health | 5/24/2010 |
| COLORADO STATE UNIVERSITY | $30,576 | Trans-NIH Recovery Act Research Support The proposed experiments are designed to thoroughly test important aspects of the hypotheses presented in the parent grant. Thus the resulting data should greatly advance understanding of how mRNA stabilization is achieved and how this process mediates th | National Institutes of Health | 7/20/2009 |
| COLORADO STATE UNIVERSITY | $16,598 | ARRA - Scholarships for Disadvantaged Students Scholarships for Disadvantaged Students in the Discipline of Veterinary Medicing | Health Resources and Services Administration | 9/03/2009 |
| COLORADO STATE UNIVERSITY | $7,163 | Trans-NIH Recovery Act Research Support The long-term objective of this work is to understand the molecular mechanisms by which hormones influence uterine smooth muscle contraction and relaxation. This proposal focuses on defining cellular and subcellular mechanisms involved in crosstalk betwee | National Institutes of Health | 7/09/2009 |